Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Phase I Trial of CD8-Depleted Human Leukocyte Antigen (HLA) Mismatched Unrelated Donor Lymphocyte Infusion (DLI) to Achieve Remissions in Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (sAML)
Phase I Trial of CD8-Depleted Human Leukocyte Antigen (HLA) Mismatched Unrelated Donor Lymphocyte Infusion (DLI) to Achieve Remissions in Myelodysplastic Syndrome (MDS) and Secondary Acute Myeloid Leukemia (sAML) Elmariah, H., Kim, J., Reid, K. M., Cubitt, C., Kuykendall, A., Lancet, J. E., Komrokji, R. S., Sallman, D. A., Chan, O., Sweet, K., Ribickas, A. J., Faramand, R., Mishra, A., Khimani, F., Perez, L., Kessler, D., Dormesy, S., Pidala, J., Anasetti, C., Fuchs, E. J., Jain, M. D., Locke, F. L., Davila, M. L., Bejanyan, N., DeZern, A. E. ELSEVIER. 2022View details for DOI 10.1182/blood-2022-168175
View details for Web of Science ID 000893223200365